AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
PHARMACOLOGY OF PRAMIPEXOLE, A DOPAMINE D-3-PREFERRING AGONIST USEFULIN TREATING PARKINSONS-DISEASE
Authors: PIERCEY MF
Citation: Mf. Piercey, PHARMACOLOGY OF PRAMIPEXOLE, A DOPAMINE D-3-PREFERRING AGONIST USEFULIN TREATING PARKINSONS-DISEASE, Clinical neuropharmacology, 21(3), 1998, pp. 141-151
CLOZAPINE, HALOPERIDOL, AND THE D-4 ANTAGONIST PNU-101387G - IN-VIVO EFFECTS ON MESOCORTICAL, MESOLIMBIC, AND NIGROSTRIATAL DOPAMINE AND SEROTONIN RELEASE
Authors: BRODERICK PA PIERCEY MF
Citation: Pa. Broderick et Mf. Piercey, CLOZAPINE, HALOPERIDOL, AND THE D-4 ANTAGONIST PNU-101387G - IN-VIVO EFFECTS ON MESOCORTICAL, MESOLIMBIC, AND NIGROSTRIATAL DOPAMINE AND SEROTONIN RELEASE, Journal of neural transmission, 105(6-7), 1998, pp. 749-767
SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF -N,N-DIMETHYL-4H-IMIDAZO[4,5,1-IJ]QUINOLIN-5-AMINE AND ITS METABOLITES
Authors: HEIER RF DOLAK LA DUNCAN JN HYSLOP DK LIPTON MF MARTIN IJ MAURAGIS MA PIERCEY MF NICHOLS NF SCHREUR PJKD SMITH MW MOON MW
Citation: Rf. Heier et al., SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF -N,N-DIMETHYL-4H-IMIDAZO[4,5,1-IJ]QUINOLIN-5-AMINE AND ITS METABOLITES, Journal of medicinal chemistry, 40(5), 1997, pp. 639-646
INTERACTIONS BETWEEN COCAINE AND (-)-DS-121 - STUDIES WITH 2-DEOXYGLUCOSE AUTORADIOGRAPHY AND MICRODIALYSIS IN THE RAT-BRAIN
Authors: KOCH S PIERCEY MF GALLOWAY MP SVENSSON KA
Citation: S. Koch et al., INTERACTIONS BETWEEN COCAINE AND (-)-DS-121 - STUDIES WITH 2-DEOXYGLUCOSE AUTORADIOGRAPHY AND MICRODIALYSIS IN THE RAT-BRAIN, European journal of pharmacology, 319(2-3), 1997, pp. 173-180
EXCITATION OF TYPE-II ANTERIOR CAUDATE NEURONS BY STIMULATION OF DOPAMINE D-3 RECEPTORS
Authors: PIERCEY MF HYSLOP DK HOFFMANN WE
Citation: Mf. Piercey et al., EXCITATION OF TYPE-II ANTERIOR CAUDATE NEURONS BY STIMULATION OF DOPAMINE D-3 RECEPTORS, Brain research, 762(1-2), 1997, pp. 19-28
HIGH-AFFINITY BINDING FOR PRAMIPEXOLE, A DOPAMINE D-3 RECEPTOR-LIGAND, IN RAT STRIATUM
Authors: PIERCEY MF WALKER EL FELDPAUSCH DL CAMACHOOCHOA M
Citation: Mf. Piercey et al., HIGH-AFFINITY BINDING FOR PRAMIPEXOLE, A DOPAMINE D-3 RECEPTOR-LIGAND, IN RAT STRIATUM, Neuroscience letters, 219(2), 1996, pp. 138-140
ANTAGONISM OF COCAINE STIMULANT EFFECTS ON LOCAL CEREBRAL GLUCOSE-UTILIZATION BY THE PREFERENTIAL AUTORECEPTOR ANTAGONIST (-AJ-76())
Authors: CASEY BL RAY CA PIERCEY MF
Citation: Bl. Casey et al., ANTAGONISM OF COCAINE STIMULANT EFFECTS ON LOCAL CEREBRAL GLUCOSE-UTILIZATION BY THE PREFERENTIAL AUTORECEPTOR ANTAGONIST (-AJ-76()), Journal of neural transmission, 103(3), 1996, pp. 277-285
PHARMACOLOGICAL CHARACTERIZATION OF U-101387, A DOPAMINE D4 RECEPTOR-SELECTIVE ANTAGONIST
Authors: MERCHANT KM GILL GS HARRIS DW HUFF RM EATON MJ LOOKINGLAND K LUTZKE BS MCCALL RB PIERCEY MF SCHREUR PJKD SETHY VH SMITH MW SVENSSON KA TANG AH VONVOIGTLANDER PF TENBRINK RE
Citation: Km. Merchant et al., PHARMACOLOGICAL CHARACTERIZATION OF U-101387, A DOPAMINE D4 RECEPTOR-SELECTIVE ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1392-1403
PHARMACOLOGY OF U-91356A, AN AGONIST FOR THE DOPAMINE D-2 RECEPTOR SUBTYPE
Authors: PIERCEY MF MOON MW SETHY VH SCHREUR PJKD SMITH MW TANG AH VONVOIGTLANDER PF
Citation: Mf. Piercey et al., PHARMACOLOGY OF U-91356A, AN AGONIST FOR THE DOPAMINE D-2 RECEPTOR SUBTYPE, European journal of pharmacology, 317(1), 1996, pp. 29-38
INHIBITION OF DOPAMINE NEURON FIRING BY PRAMIPEXOLE, A DOPAMINE D-3 RECEPTOR-PREFERRING AGONIST, COMPARISON TO OTHER DOPAMINE-RECEPTOR AGONISTS
Authors: PIERCEY MF HOFFMANN WE SMITH MW HYSLOP DK
Citation: Mf. Piercey et al., INHIBITION OF DOPAMINE NEURON FIRING BY PRAMIPEXOLE, A DOPAMINE D-3 RECEPTOR-PREFERRING AGONIST, COMPARISON TO OTHER DOPAMINE-RECEPTOR AGONISTS, European journal of pharmacology, 312(1), 1996, pp. 35-44
EXCITATION OF TYPE-II CAUDATE NEURONS BY SYSTEMIC ADMINISTRATION OF DOPAMINE AGONISTS
Authors: PIERCEY MF HYSLOP DK HOFFMAN WE
Citation: Mf. Piercey et al., EXCITATION OF TYPE-II CAUDATE NEURONS BY SYSTEMIC ADMINISTRATION OF DOPAMINE AGONISTS, Brain research, 706(2), 1996, pp. 249-258
DOPAMINE-RECEPTOR SUBTYPES IN NEUROLOGICAL AND PSYCHIATRIC DISEASE
Authors: CARLSSON A PIERCEY MF
Citation: A. Carlsson et Mf. Piercey, DOPAMINE-RECEPTOR SUBTYPES IN NEUROLOGICAL AND PSYCHIATRIC DISEASE, Clinical neuropharmacology, 18, 1995, pp. 1-5
FUNCTIONAL ROLES FOR DOPAMINE-RECEPTOR SUBTYPES
Authors: PIERCEY MF CAMACHOOCHOA M SMITH MW
Citation: Mf. Piercey et al., FUNCTIONAL ROLES FOR DOPAMINE-RECEPTOR SUBTYPES, Clinical neuropharmacology, 18, 1995, pp. 34-42
RAT-BRAIN BINDING-SITES FOR PRAMIPEXOLE, A CLINICALLY USEFUL D-3-PREFERRING DOPAMINE AGONIST
Authors: CAMACHOOCHOA M WALKER EL EVANS DL PIERCEY MF
Citation: M. Camachoochoa et al., RAT-BRAIN BINDING-SITES FOR PRAMIPEXOLE, A CLINICALLY USEFUL D-3-PREFERRING DOPAMINE AGONIST, Neuroscience letters, 196(1-2), 1995, pp. 97-100
CONTINUOUS ADMINISTRATION DECREASES AND PULSATILE ADMINISTRATION INCREASES BEHAVIORAL SENSITIVITY TO A NOVEL DOPAMINE D-2 AGONIST (U-91356A) IN MPTP-EXPOSED MONKEYS
Authors: BLANCHET PJ CALON F MARTEL JC BEDARD PJ DIPAOLO T WALTERS RR PIERCEY MF
Citation: Pj. Blanchet et al., CONTINUOUS ADMINISTRATION DECREASES AND PULSATILE ADMINISTRATION INCREASES BEHAVIORAL SENSITIVITY TO A NOVEL DOPAMINE D-2 AGONIST (U-91356A) IN MPTP-EXPOSED MONKEYS, The Journal of pharmacology and experimental therapeutics, 272(2), 1995, pp. 854-859
LEVODOPA OR D2 AGONIST-INDUCED DYSKINESIA IN MPTP MONKEYS - CORRELATION WITH CHANGES IN DOPAMINE AND GABA(A) RECEPTORS IN THE STRIATOPALLIDAL COMPLEX
Authors: CALON F GOULET M BLANCHET PJ MARTEL JC PIERCEY MF BEDARD PJ DIPAOLO T
Citation: F. Calon et al., LEVODOPA OR D2 AGONIST-INDUCED DYSKINESIA IN MPTP MONKEYS - CORRELATION WITH CHANGES IN DOPAMINE AND GABA(A) RECEPTORS IN THE STRIATOPALLIDAL COMPLEX, Brain research, 680(1-2), 1995, pp. 43-52
METABOLIC EFFECTS OF SCOPOLAMINE AND PHYSOSTIGMINE IN HUMAN BRAIN - MEASURED BY POSITRON EMISSION TOMOGRAPHY
Authors: BLIN J PIERCEY MF GIUFFRA ME MOURADIAN MM CHASE TN
Citation: J. Blin et al., METABOLIC EFFECTS OF SCOPOLAMINE AND PHYSOSTIGMINE IN HUMAN BRAIN - MEASURED BY POSITRON EMISSION TOMOGRAPHY, Journal of the neurological sciences, 123(1-2), 1994, pp. 44-51
CHARACTERIZATION OF U-92016A AS A SELECTIVE, ORALLY-ACTIVE, HIGH INTRINSIC ACTIVITY 5-HYDROXYTRYPTAMINE(1A) AGONIST
Authors: MCCALL RB ROMERO AG BIENKOWSKI MJ HARRIS DW MCGUIRE JC PIERCEY MF SHUCK ME SMITH MW SVENSSON KA SCHREUR PJKD CARLSSON A VONVOIGTLANDER PF
Citation: Rb. Mccall et al., CHARACTERIZATION OF U-92016A AS A SELECTIVE, ORALLY-ACTIVE, HIGH INTRINSIC ACTIVITY 5-HYDROXYTRYPTAMINE(1A) AGONIST, The Journal of pharmacology and experimental therapeutics, 271(2), 1994, pp. 875-883
EXCITATION OF NORADRENERGIC CELL FIRING BY 5-HYDROXYTRYPTAMINE(1A) AGONISTS CORRELATES WITH DOPAMINE ANTAGONIST PROPERTIES
Authors: PIERCEY MF SMITH MW LUMRAGAN JT
Citation: Mf. Piercey et al., EXCITATION OF NORADRENERGIC CELL FIRING BY 5-HYDROXYTRYPTAMINE(1A) AGONISTS CORRELATES WITH DOPAMINE ANTAGONIST PROPERTIES, The Journal of pharmacology and experimental therapeutics, 268(3), 1994, pp. 1297-1303
PHARMACOLOGY OF A MIXED 5-HYDROXYTRYPTAMINE(1A) DOPAMINE AGONIST/
Authors: PIERCEY MF TANG AH LAHTI RA VONVOIGTLANDER PF SCHREUR PJKD MCCALL RB LUMRAGAN JT HOFFMANN WE FRANKLIN SR CODE RA SMITH MW SZMUSZKOVICZ J
Citation: Mf. Piercey et al., PHARMACOLOGY OF A MIXED 5-HYDROXYTRYPTAMINE(1A) DOPAMINE AGONIST/, The Journal of pharmacology and experimental therapeutics, 268(3), 1994, pp. 1304-1310
COMPARISON OF CHOLINERGIC DRUG EFFECTS ON REGIONAL BRAIN GLUCOSE CONSUMPTION IN RATS AND HUMANS BY MEANS OF AUTORADIOGRAPHY AND POSITRON EMISSION TOMOGRAPHY
Authors: BLIN J RAY CA PIERCEY MF BARTKO JJ MOURADIAN MM CHASE TN
Citation: J. Blin et al., COMPARISON OF CHOLINERGIC DRUG EFFECTS ON REGIONAL BRAIN GLUCOSE CONSUMPTION IN RATS AND HUMANS BY MEANS OF AUTORADIOGRAPHY AND POSITRON EMISSION TOMOGRAPHY, Brain research, 635(1-2), 1994, pp. 196-202
EVALUATION OF THE REINFORCING AND DISCRIMINATIVE STIMULUS EFFECTS OF COCAINE IN COMBINATION WITH (-AJ-76 OR CLOZAPINE())
Authors: VANOVER KE PIERCEY MF WOOLVERTON WL
Citation: Ke. Vanover et al., EVALUATION OF THE REINFORCING AND DISCRIMINATIVE STIMULUS EFFECTS OF COCAINE IN COMBINATION WITH (-AJ-76 OR CLOZAPINE()), The Journal of pharmacology and experimental therapeutics, 266(2), 1993, pp. 780-789
CENTRALLY ACTING SEROTONERGIC AND DOPAMINERGIC AGENTS .1. SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2,3,3A,4,5,9B-HEXAHYDRO-1H-BENZ[E]INDOLE DERIVATIVES
Authors: LIN CH HAADSMASVENSSON SR LAHTI RA MCCALL RB PIERCEY MF SCHREUR PJKD VONVOIGTLANDER PF SMITH MW CHIDESTER CG
Citation: Ch. Lin et al., CENTRALLY ACTING SEROTONERGIC AND DOPAMINERGIC AGENTS .1. SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2,3,3A,4,5,9B-HEXAHYDRO-1H-BENZ[E]INDOLE DERIVATIVES, Journal of medicinal chemistry, 36(8), 1993, pp. 1053-1068
CENTRALLY ACTING SEROTONERGIC AND DOPAMINERGIC AGENTS .2. SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2,3,3A,4,9,9A-HEXAHYDRO-1H-BENZ[F]INDOLE DERIVATIVES
Authors: LIN CH HAADSMASVENSSON SR PHILLIPS G LAHTI RA MCCALL RB PIERCEY MF SCHREUR PJKD VONVOIGTLANDER PF SMITH MW CHIDESTER CG
Citation: Ch. Lin et al., CENTRALLY ACTING SEROTONERGIC AND DOPAMINERGIC AGENTS .2. SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2,3,3A,4,9,9A-HEXAHYDRO-1H-BENZ[F]INDOLE DERIVATIVES, Journal of medicinal chemistry, 36(8), 1993, pp. 1069-1083
SUBSTITUTED 3-PHENYLPIPERIDINES - NEW CENTRALLY ACTING DOPAMINE AUTORECEPTOR ANTAGONISTS
Authors: SONESSON C WATERS N SVENSSON K CARLSSON A SMITH MW PIERCEY MF MEIER E WIKSTROM H
Citation: C. Sonesson et al., SUBSTITUTED 3-PHENYLPIPERIDINES - NEW CENTRALLY ACTING DOPAMINE AUTORECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 36(21), 1993, pp. 3188-3196
Risultati: 1-25 | 26-29